BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.53M | 82.56M | 74.49M | 74.49M | 41.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.53M | 82.56M | 74.49M | 74.49M | 41.90M |
| Cost of Revenue | 853.40K | 4.24M | 3.75M | 3.75M | 2.22M |
| Gross Profit | 71.67M | 78.32M | 70.74M | 70.74M | 39.68M |
| SG&A Expenses | 64.68M | 68.49M | 61.79M | 61.79M | 34.95M |
| Depreciation & Amortization | 54.00K | 56.80K | 54.10K | 54.10K | 51.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.28M | 73.26M | 65.67M | 65.67M | 37.30M |
| Operating Income | 5.25M | 9.29M | 8.82M | 8.82M | 4.61M |
| Income Before Tax | 5.28M | 9.15M | 8.68M | 8.68M | 4.44M |
| Income Tax Expenses | 797.40K | 2.33M | 2.31M | 2.31M | 1.18M |
| Earnings from Continuing Operations | 4.48M | 6.82M | 6.36M | 6.36M | 3.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.48M | 6.82M | 6.36M | 6.36M | 3.26M |
| EBIT | 5.25M | 9.29M | 8.82M | 8.82M | 4.61M |
| EBITDA | 5.30M | 9.35M | 8.87M | 8.87M | 4.66M |
| EPS Basic | 0.27 | 0.42 | 0.39 | 0.39 | 0.20 |
| Normalized Basic EPS | 0.20 | 0.35 | 0.33 | 0.33 | 0.17 |
| EPS Diluted | 0.17 | 0.32 | 0.30 | 0.30 | 0.17 |
| Normalized Diluted EPS | 0.13 | 0.27 | 0.25 | 0.25 | 0.14 |
| Average Basic Shares Outstanding | 16.67M | 16.32M | 16.30M | 16.30M | 16.32M |
| Average Diluted Shares Outstanding | 26.26M | 21.13M | 21.35M | 21.35M | 19.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |